- Home
- BHVN
BHVN
Biohaven Ltd.
as 09-12-2025 12:31pm EST
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | NEW HAVEN |
| Market Cap: | 1.5B | IPO Year: | 2017 |
| Target Price: | $56.07 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.79 - $55.70 | Next Earning Date: | 11-11-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 2002.87% |
Latest Biohaven Ltd. News
BHVN Breaking Stock News: Dive into BHVN Ticker-Specific Updates for Smart Investing
Motley Fool
21 days ago
Why Biohaven Stock Zoomed More Than 6% Higher Today
Investor's Business Daily
21 days ago
Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News?
MT Newswires
21 days ago
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires
21 days ago
Sector Update: Health Care Stocks Higher in Afternoon Trading
MT Newswires
21 days ago
Biohaven Says US FDA Deems Advisory Committee Meeting No Longer Needed on Troriluzole
Benzinga
21 days ago
Biohaven Advances Toward Potential First FDA-Approved Therapy For Spinocerebellar Ataxia, FDA Drops Advisory Meeting
BioPharma Dive
21 days ago
FDA cancels adcomm on Biohaven drug; Catalent lays off staff
TipRanks
23 days ago
RBC says PTC Therapeutics CRL may signal difficulty for Biohaven
Compare BHVN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BHVN Biohaven Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.